Skip to content
Revival RXPartners
Growth hormone secretagogue

CJC-1295, and the formulation detail that matters.

The compound name covers more than one formulation, and treating them as interchangeable is a menu error clinics make early.

What it is

CJC-1295 is a synthetic peptide in the growth hormone secretagogue category, structurally a modified fragment of growth hormone-releasing hormone. It is compounded, dispensed against a prescription, and is not an approved drug product.

One name, more than one preparation

The single most common operational mistake here is treating the name as if it referred to one thing. It covers formulations that differ meaningfully in how they are prepared and how a pharmacy handles them, and a clinic menu that lists the name without the formulation will eventually produce a mismatch between what a patient was told and what arrives.

For menu purposes, the discipline is simple: name what you actually carry, confirmed against what your partner pharmacy actually prepares.

Which pharmacy path applies

Typically 503(a) patient-specific, and as with ipamorelin, combination availability is pharmacy-dependent and needs confirming before the offering is published.

Menu fit

Same category and same patient conversation as the rest of the secretagogue group, and it usually enters a menu alongside them rather than on its own.

This library is written for clinic operators making menu, sourcing and inventory decisions. It is not medical advice, contains no dosing or protocol guidance, and makes no claim about the safety or effectiveness of any compounded preparation. Compounded medications are not FDA-approved. What any individual patient should receive is a decision for a licensed practitioner.

FAQ

CJC-1295 questions.

  • Why does the formulation distinction matter operationally?

    Because the name alone does not tell your staff or your patient what is being prepared. A menu that lists the name without the formulation eventually produces a mismatch between the consultation and the shipment.

  • Is it usually combined?

    Often, and what can be combined depends on the preparing pharmacy. Confirm before publishing the offering.

Your patients are already asking about peptides.Make sure your clinic is ready to answer.

Build and launch your peptide program with Revival RX Partners in 90 days.

Important

  • Revival RX Partners is a consulting and sourcing partner. It is not a pharmacy, does not compound or dispense medication, and does not practice medicine or provide medical advice.
  • All medications are dispensed by licensed partner pharmacies against valid prescriptions issued by your clinic's licensed prescribers.
  • Compounded peptides are not FDA-approved products. Availability, regulatory status, and pharmacy capability vary by compound and by state, and are subject to change.
  • Nothing on this page is a guarantee of revenue, patient volume, or clinical outcomes. Revenue figures shown are illustrative and generated from values you enter.